Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A functional role for corpora amylacea based on evidence from complement studies

S K Singhrao1, B P Morgan, J W Neal

  • 1EM Unit, University of Wales College of Medicine, Cardiff.

Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Ethnic differences in complement system biomarkers and their association with metabolic health in men of Black African and White European ethnicity.

Clinical and experimental immunology·2023
Same author

Periodontitis and Dementia: A Bidirectional Relationship?

Journal of dental research·2021
Same author

The rare C9 P167S risk variant for age-related macular degeneration increases polymerization of the terminal component of the complement cascade.

Human molecular genetics·2021
Same author

Periodontitis to dementia or converse?

British dental journal·2019
Same author

Evolving concepts of chronic traumatic encephalopathy as a neuropathological entity.

Neuropathology and applied neurobiology·2017
Same journal

The bridging concept: optimizing dose for phase II/III in Alzheimer's disease.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
Same journal

Current approaches to the treatment of Alzheimer's disease.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
Same journal

Cellular aspects of the inflammatory response in Alzheimer's disease.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
Same journal

Glial cell derived neurotrophic factors and Alzheimer's disease.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
Same journal

Neurotransmitter receptor/G-protein mediated signal transduction in Alzheimer's disease brain.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
Same journal

From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer's disease.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
See all related articles

Corpora amylacea (CA) in the aging brain and CNS diseases are linked to complement activation. This suggests CA may protect the central nervous system (CNS) by masking immunogenic proteins.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Corpora amylacea (CA) are found in the aging brain and central nervous system (CNS) under neurological conditions.
  • Proteins from neurons and oligodendrocytes are present within CA.

Purpose of the Study:

  • To investigate the complement system's role in the formation and potential function of corpora amylacea (CA).

Main Methods:

  • Immunohistochemistry and Western immunoblotting were used to analyze CA from brain tissue of patients with Alzheimer's disease, multiple sclerosis, and Pick's disease.
  • Complement activity and specific complement components within CA and surrounding structures were assessed.

Main Results:

  • Corpora amylacea (CA) showed immunopositivity for classical complement pathway components, including C3d and the terminal complement complex (TCC).

Related Experiment Videos

  • CA were immunonegative for alternative pathway proteins but positive for regulators like membrane cofactor protein (MCP), S-protein, and clusterin.
  • A filamentous fringe around CA, likely astrocytic, also stained positive for complement factors.

    • Conclusions:

    • Corpora amylacea (CA) formation involves the classical complement pathway, suggesting an inflammatory or protective response within the CNS.
    • CA may function to sequester ubiquitinated proteins from damaged neurons and oligodendrocytes, preventing immune recognition and protecting the CNS from further injury.